Compare INUV & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INUV | IOBT |
|---|---|---|
| Founded | N/A | 2014 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Advertising | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.5M | 57.2M |
| IPO Year | N/A | 2021 |
| Metric | INUV | IOBT |
|---|---|---|
| Price | $2.77 | $0.75 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $14.00 | $3.50 |
| AVG Volume (30 Days) | 97.2K | ★ 919.6K |
| Earning Date | 11-06-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $98,139,861.00 | N/A |
| Revenue This Year | $20.86 | N/A |
| Revenue Next Year | $14.59 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 25.11 | N/A |
| 52 Week Low | $2.34 | $0.32 |
| 52 Week High | $7.90 | $2.79 |
| Indicator | INUV | IOBT |
|---|---|---|
| Relative Strength Index (RSI) | 48.20 | 48.38 |
| Support Level | $2.76 | $0.59 |
| Resistance Level | $2.97 | $0.76 |
| Average True Range (ATR) | 0.18 | 0.09 |
| MACD | 0.05 | 0.00 |
| Stochastic Oscillator | 66.49 | 65.48 |
Inuvo Inc develops and sells information technology solutions for marketing. It develops technology to deliver content and targeted advertisements over the internet. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.